SynerFuse® is developing a new approach to treating chronic spine-related pain without opioids. Chronic lower back pain remains one of the leading causes of disability worldwide, and many patients continue to experience persistent pain even after spinal fusion surgery. SynerFuse® is pioneering an integrated approach that combines spinal fusion with targeted nerve modulation in a single surgical platform designed to improve long-term patient outcomes. Our mission is to help surgeons address the root causes of chronic spine pain while reducing dependence on opioid-based pain management. CAUTION ~ Investigational device. Limited by U.S. federal law to investigational use.
| Website | https://www.synerfuse.com/ |
| Employees | 9 (4 on RocketReach) |
| Founded | 2018 |
| Address | 6321 Bury Dr Suite 10, Minneapolis, Minnesota 55346, US |
| Phone | +1 612-470-2975 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Therapeutics, Therapeutic Devices, Health Care |
| Keywords | Pain Management, Chronic Pain Relief, Neuromodulation, Regenerative Medicine, Combination Therapy, Pain Therapy, Electrotherapy, Drug Free Pain Relief, Alternative Pain Management, Innovative Pain Treatment, Advanced Pain Management, Peripheral Nerve Stimulation, Spinal Cord Stimulation |
| Competitors | Medtronic, Stryker, Boston Scientific, Smith+Nephew, B. Braun Group, Spinal Resources, K2M, Johnson & Johnson MedTech Germany, Impulse Monitoring +28 more (view full list) |
Looking for a particular SynerFuse employee's phone or email?
Nameer Haider is the Chief Innovation Officer of SynerFuse.
4 people are employed at SynerFuse.
SynerFuse is based in Minneapolis, Minnesota.